Introduction {#S0001}
============

A large data analysis revealed that the unplanned admission and readmission rates after laparoscopic cholecystectomy (LC) are very low; however, pain continues to be an important issue after LC that results in prolonged admissions or readmissions.[@CIT0001] Khan et al concluded that an ultrasound-guided subcostal transversus abdominis plane block (TAPB) provides better postoperative analgesia compared to the a posterior TAPB for LC, and both of these approaches improve patient outcomes in terms of early recovery and discharge from hospital.[@CIT0002] However, the additional effect of analgesia with ultrasound-guided posterior TAPB is presumed to be caused by a reduction in visceral pain related to sympathetic nerve block.[@CIT0003] A rectus sheath block (RSB) can provide analgesia for small subxiphoid incision where the nerves from T6-T8 course.[@CIT0004],[@CIT0005] Thus, an RSB might be useful for pain control for incision in the subxiphoid area. Another study reported that the combination of an RSB and TAPB effectively controlled pain after LC and decreased numeric rating scale scores.[@CIT0006] Local anesthetic infiltration (LAI) at the trocar entrance sites is a technique that has been shown to decrease pain and opioid requirements after LC and is commonly used by surgeons; furthermore, we concluded that incisional infiltration of ropivacaine combined with dexmedetomidine could significantly reduce postoperative pain and analgesic requirement; this technique also facilitated early mobilization and enhanced the postoperative analgesic effects and sleep quality during the first night after LC without increasing the incidence of surgical adverse events.[@CIT0007]

We hypothesized that ultrasound-guided peripheral nerve blocks of the abdominal wall would lead to lower postoperative pain scores after LC than LAI of the trocar insertion sites.

Materials and methods {#S0002}
=====================

This randomized, double-blind, non-inferiority study was approved by the Institutional Research Ethics Committee of The First People's Hospital of Hefei (No. 2015-11) and already registered in the Chinese Clinical Trial Registry (ChiCTR-IOR-16009912). Written informed consent was obtained from all study subjects, and the study was conducted in accordance with the Declaration of Helsinki. The patients and staff responsible for the data collection were blinded to the study.

The exclusion criteria were as follows: patients with a body mass index (BMI) ≥30 kg/m^2^, age \<18 years or \>65 years, hepatic or renal disease, coagulopathy, history of alcohol or drug abuse, ASA physical status III or greater, pregnant patients, patients with a past medical history of chronic pain (such as fibromyalgia or low back pain), patients at risk for taking NSAIDs, those with allergies to medication or those receiving medication treatment within 3 months (dexmedetomidine and ropivacaine), and patients who could not obey commands were excluded from our study. Moreover, patients were excluded if the surgery was converted to an open procedure or a drainage catheter was placed.

All patients who underwent 3-port LC procedures performed by surgeons trained in laparoscopy were randomly divided into 3 groups. Group assignments were placed inside numbered opaque envelopes. The LAI group had ropivacaine mixed with dexmedetomidine injected around the trocar entrance sites. The TL group underwent ultrasound-guided posterior TAPB combined with LAI, and the TR group underwent ultrasound-guided subcostal TAPB combined with RSB. All injections were performed before skin incision. The LAI group received preincisional infiltration of 0.5% ropivacaine mixed with 1 μg/kg dexmedetomidine in a total volume of 30 ml, as in the previous study.[@CIT0007] The TL and TR groups received 0.25% ropivacaine mixed with 1 μg/kg of dexmedetomidine in a total volume of 60 ml (30 ml for bilateral posterior TAPB and preincisional infiltration in the TL group). In addition, 40 ml of the mixture was used for bilateral TAPB and 20 ml for bilateral RSB in the TR group. The ultrasound-guided peripheral nerve blocks of the abdominal wall were performed by anesthesiologists with significant experience with this technique.

During the preoperative interview, the patients were introduced to the concept of the visual analogue scale (VAS), in which a 10-cm vertical score ranges from 0= no pain to 10= worst pain imaginable. The VAS was used to assess the postoperative pain of each patient at different time points after surgery. The effect on pain intensity was evaluated with the VAS and the amount of analgesics used.

All patients underwent general anesthesia with the same protocol. Intraoperative continuous monitoring included a five-lead electrocardiogram, noninvasive blood pressure, pulse oxygen saturation, Narcotrend (Narcotrend-Compact, MT Monitior Technik GmbH & Co., Bad Bramstedt, Germany) parameters and end-tidal CO~2~. No patient received premedication, and venous access was established for infusion of lactated Ringer's solution when they arrived at the operating room. All patients received an intravenous injection of 1.5 mg/kg of flurbiprofen axetil (a type of NSAID) 10 min before anesthesia induction, which was repeated 6 h after surgery. Then, anesthesia was induced with 1 μg/kg of remifentanil and 1.5--2.5 mg/kg of propofol, followed by 0.15 mg/kg of cisatracurium to facilitate tracheal intubation. The infusions of remifentanil and propofol were continued at 0.1--0.5 μg·kg^−1^·h^−1^ and 3--12 μg·kg^−1^·h^−1^, respectively, immediately after the loading doses were administered to maintain the Narcotrend Index between 40 and 60 during the procedure. After endotracheal intubation, all patients were provided with mechanical ventilation. Minute ventilation was adjusted to keep end-tidal CO~2~ at 35--45 mmHg. During laparoscopy, the intra-abdominal pressure of the CO~2~ pneumoperitoneum was maintained at 12 mmHg. CO~2~ was carefully excreted at the end of surgery by manual compression of the abdomen through the open trocars. Residual neuromuscular blockade was reversed with 1 mg/kg of neostigmine, and 0.5 mg of atropine was administered. During closure of the skin, tropisetron (2 mg) was administered intravenously.

The VAS score was recorded at the following time points: 1 hr (T1), 4 hrs (T2), 8 hrs (T3), 24 hrs (T4), and 48 hrs (T5) after surgery. If the VAS score (including incisional pain, visceral pain or shoulder pain) was \>3, 5 mg of dezocine was injected intramuscularly.

Awakening time from anesthesia, time to unassisted walking, sleep quality (if the patient awoke because of pain on the first postoperative night or not), the total consumption of dezocine, and the number of patients experiencing postoperative nausea and vomiting (PONV) were recorded. The Global Satisfaction Score (GSS)[@CIT0008] was also assessed within 48 hrs. The GSS was used to evaluate patients' satisfaction with pain control and was reported as follows: "poor =1", "fair =2", "good =3", or "very good =4". The number of patients who experienced PONV was also recorded. Patients were hospitalized for up to 48 hrs as part of our routine practice.

In a pilot study, we found that patients receiving LAI expressed more satisfaction than patients in whom other methods were used (n=30 patients, 10 patients per group, GSS: 3.60±0.5, 3.10±0.7 and 3.0±0.9, respectively). To achieve 80% power and an α-error of 5%, the total sample size was 144, as calculated using G\*Power 3.1.9.4 software. Then, a total of 180 American Society of Anesthesiologists (ASA) status Ι or II patients were scheduled for elective LC with 3 trocar sites under general anesthesia and were enrolled in this study.

Data are expressed as the mean ± standard deviation (SD) or mean ± standard error of the mean (SEM). Parametric data were compared between groups by analysis of variance and post hoc testing. Statistical significance was assumed if *P*\<0.05. Multiple comparisons between the groups were performed using the S-N-K method. Nonparametric data were analysed using χ^2^ tests between groups. All statistical analyses were performed with the Statistical Package for Social Sciences (SPSS) software 13.0.

Results {#S0003}
=======

[Figure 1](#F0001){ref-type="fig"} shows the flowchart of the study design for the inclusion of patients. One hundred eighty patients underwent 3-port LC, and the 48 hr post-LC evaluation period was considered for the final analysis.Figure 1Consolidated Standards of Reporting Trials (CONSORT) flow diagram.

There were no significant differences among the 3 groups with respect to age, weight, height, sex, ASA physical status, duration of surgery, awakening time from anesthesia, time to unassisted walking, sleep quality and number of patients experiencing PONV. In addition, we summarized the characteristics of patients who underwent elective LC and the distribution of 3 types of gallbladder disease observed in these patients ([Table 1](#T0001){ref-type="table"}).Table 1Demographic characteristics of patients undergoing laparoscopic cholecystectomy (LC)Group LAI\
(n=60)Group TL\
(n=60)Group TR\
(n=60)Age (years)48.0±11.447.6±10.148.6±12.1Weight (kg)65.5±7.966.3±9.364.5±9.3Height (cm)163.5±5.8163.3±7.7163.7±7.4Sex (female/male)19/4117/4320/40ASA class (І/П)27/3329/3131/29Duration of surgery (min)48.1±12.746.5±10.645.8±11.8Awaking time of anesthesia (min)4.4±2.84.5±2.64.2±2.6Time to unassisted walking (h)62.3±35.560.3±25.662.2±33.0Waking up (yes/no)5/557/538/52PONV (cases)576Gallstones with chronic cholecystitis565555Gallstone121Gallbladder polyps334[^1]

There were no significant differences in VAS scores and the consumption of dezocine among the three groups, but the VAS scores in the LAI group tended to be lower at all time points ([Figure 2](#F0002){ref-type="fig"}). However, patients receiving LAI at the trocar insertion sites expressed more satisfaction than patients in the other two groups (*P*\<0.001, [Figure 3](#F0003){ref-type="fig"}).Figure 2Postoperative Visual Analog Scale (VAS) score at different time point after laparoscopic cholecystectomy (LC) (**A**) and the total consumption of dezocine (**B**). Data are presented as mean ± SEM. Group LAI = ropivacaine combining with dexmedetomidine infiltration and injection in incision sites, TL = ultrasound-guided posterior TAPB combined with LAI, TR = ultrasound-guided subcostal TAPB combined with RSB.Figure 3Global Satisfaction Score (GSS) within 48 hrs after laparoscopic cholecystectomy (LC). Data are presented as mean ± SD. \* *P*\<0.001 vs Group LAI. Group LAI = ropivacaine combining with dexmedetomidine infiltration and injection in incision sites, TL = ultrasound-guided posterior TAPB combined with LAI, TR = ultrasound-guided subcostal TAPB combined with RSB.

Discussion {#S0004}
==========

Ortiz et al reported[@CIT0009] that bilateral ultrasound-guided TAPB is equivalent to incisional infiltration for overall postoperative pain in patients undergoing LC. In addition, subcostal TAPB could be considered preferable because it can be applied easily and in a shorter time.[@CIT0010] It is possible that TAPB could be more beneficial during conventional surgery. For this non-inferiority study, we concluded that there were no significant differences in VAS scores among the three groups; however, patients receiving LAI at the trocar insertion sites expressed more satisfaction than patients in whom other methods were used. Interestingly, we found a recent study supporting our conclusions. They reported[@CIT0011] that both TAPB and LAI shared a benefit in terms of primary outcomes for LC, and LAI was more effective for postoperative analgesia, easier to apply and safer than other analgesic methods. On the other hand, we did not find that ultrasound-guided posterior TAPB had an additional effect on reducing visceral pain, as reported previously.[@CIT0003]

Ultrasound-guided TAPB was used for the treatment of pain after LC for the first time by El-Dawlatly et al in 2009.[@CIT0012] Since then, many other similar investigations have been performed.[@CIT0009],[@CIT0013]--[@CIT0017] Clearly, the location of injection into the TAP alters the spread and effect of TAPB. Hebbard proposed that the range of TAP injections should be classified as follows: upper subcostal TAP (deep to the rectus, mainly covering T7 and T8); lower subcostal TAP (lateral to the rectus, mainly covering T9-11); lateral TAP (midway between the costal margin and the iliac crest along the mid-clavicular line, mainly covering T11 and T12).[@CIT0005] Another study showed that an ultrasound-guided TAP injection cephalad to the iliac crest is likely to involve the T10-L1 nerve roots and implied that the technique might be limited to use in lower abdominal surgery.[@CIT0018] Therefore, TAPB may have some beneficial effect in reducing pain and opioid requirements after LC, but this effect is likely small.[@CIT0013] Single-incision LC using an ultrasound-guided RSB significantly reduced postoperative pain.[@CIT0019] In addition, an RSB can provide analgesia for smack subxiphoid incisions along the course of T6-T8,[@CIT0004],[@CIT0005] which might be useful for pain control for incisions in the subxiphoid area. In our routine practice, the gallbladder is removed through a subxiphoid incision. Therefore, we emphasized pain relief for patients with subxiphoid incisions.

Adequately treating postoperative pain can decrease the opioid exposure risk and potentially prevent the diversion of excess medication for abuse.[@CIT0020] We reported that incisional infiltration of 150 mg of ropivacaine combined with 1 μg/kg of dexmedetomidine was safe and efficient for postoperative pain relief after LC.[@CIT0007] Dexmedetomidine has many advantages as a multifaceted drug in perioperative medicine.[@CIT0021] Perineural dexmedetomidine added to ropivacaine provides an increased duration of analgesia and improves postoperative pain,[@CIT0022],[@CIT0023] and it was reported that the addition of dexmedetomidine to ropivacaine in TAPB had prolonged postoperative analgesia and reduced opioid consumption without any major adverse effects.[@CIT0024] Furthermore, dexmedetomidine administration also reduces the secretion of cytokines, leucocyte counts and C-reactive protein (CRP) levels, shifts the cytokine balance of T cells, and exhibits immunomodulatory effects after LC.[@CIT0025]--[@CIT0027] The anti-inflammatory effects of dexmedetomidine can help to improve postoperative pain. Thus, we used dexmedetomidine in this study. To standardize the drug doses, the concentration of ropivacaine used in the peripheral nerve blocks in the abdominal wall groups was reduced by half. Further studies should confirm whether the GSS was influenced by the concentration of the drug. On the other hand, the volume of local anesthetic used in the LAI group of our protocol was 30 ml, which was more than that used in previous research. This volume could provide sufficient local blockade.

The use of short-acting anesthetics, such as remifentanil, has introduced a "fast-track anesthesia" concept in LC[@CIT0028] and a lower dose of remifentanil is equally effective in controlling stress hormones during LC.[@CIT0029] Thus, the time to unassisted walking in this study was shorter than that in previous research. However, a systematic review and meta-analysis reported that exposure to a high dose of short-acting remifentanil was associated with the development of hyperalgesia and led to significantly increased acute pain after surgery.[@CIT0030] However, this pain was efficiently alleviated or even prevented by dexmedetomidine or co-administration of flurbiprofen axetil.[@CIT0031] On the other hand, NSAIDs were recommended as a basic analgesic technique.[@CIT0032] In our study, flurbiprofen axetil might have been a promising method for attenuating opioid-induced hyperalgesia and postoperative pain.

Several important factors influenced the outcome of this study. Firstly, the proficiency of minimally invasive surgery and the grasp of technical details were important; therefore, all of the 3-port LC procedures in this study were performed by professionally trained surgeons. Secondly, the ultrasound-guided peripheral nerve blocks of the abdominal wall were performed by anesthesiologists with significant experience, which could minimize or avoid possible errors in pain relieve. Finally, dezocine should be injected intramuscularly immediately once the VAS score \>3 as this could affect the GSS.

There are several limitations to our study. For example, there was no correct assessment of the success rate of the ultrasound-guided peripheral nerve blocks of the abdominal wall as it was performed after the induction of general anesthesia and not by the same operator; however, we relied on the skills of the investigators and the use of ultrasound to accurately place the blocking needle according to the report by Sarvesh et al[@CIT0024]. Another limitation is that it has been reported[@CIT0033] that ultrasound-guided erector spinae plane blocks (ESPBs) reduce postoperative analgesic use and pain scores more effectively than oblique subcostal TAPB after LC. Therefore, further well-designed studies are needed to confirm the differences between ESPB and LAI for patients undergoing LC.

Conclusion {#S0005}
==========

Ultrasound-guided peripheral nerve blocks of the abdominal wall can significantly relieve postoperative pain in patients undergoing LC; however, patients receiving LAI expressed more satisfaction than patients in whom other methods were used. LAI is an easy and effective method that can be recommended for routine clinical practice in LC patients who are not converted to an open procedure.
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[^1]: **Notes:** Data are presented as mean ± SD or the number of patients. Group LAI = ropivacaine combining with dexmedetomidine infiltration and injection in incision sites, TL = ultrasound-guided posterior TAPB combined with LAI, TR = ultrasound-guided subcostal TAPB combined with RSB.
